Trial Profile
Repetitive Transcranial Magnetic Stimulation Efficacy for Major Resistant Depression Compared or Associated With Venlafaxine : a Multicentric Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2011 Planned end date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 22 Jun 2011 Planned end date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov.